Chronic effects of angiotensin-converting enzyme inhibition on kinin receptor binding sites in the rat spinal cord

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 6 53-6, 2003, Pages

  Ongali, Brice ^a   De Sousa Buck, Hudson ^a   Cloutier, Frank ^a   Legault, Francine ^a   Regoli, Domenico ^c   Lambert, Chantal ^a   Thibault, Gaétan ^b   Couture, Réjean ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

B1 receptor; B2 receptor; Bradykinin; Hypertension

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; LOSARTAN; LOSARTAN POTASSIUM; ZOFENOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BLOOD PRESSURE; CONTROLLED STUDY; ENZYME INHIBITION; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; REGULATORY MECHANISM; SPINAL CORD; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0038701025     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01113.2002     Document Type: Article

References (46)

1. 1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature 407: 94-98, 2000.
2. 2 receptor in agonist-induced receptor dimerization. J Biol Chem 274: 26079-26084, 1999.
3. 2 kinin receptor within the plasma membrane of native endothelial cells. Circulation 99: 2034-2040, 1999.
4. Buikema H, Monnink SHJ, Tio RA, Crijns HJGM, de Zeeuw D, and van Gilst WH. Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure. Br J Pharmacol 130: 1999-2007, 2000.
5. 2 receptors in bradykinin-induced rat paw oedema. Br J Pharmacol 114: 1005-1013, 1995.
6. 2 receptors in the spinal cord of spontaneously hypertensive rats. Br J Pharmacol 135: 1641-1654, 2002.
7. Couture R, Harrisson M, Vianna RM, and Cloutier F. Kinin receptors in pain and inflammation. Eur J Pharmacol 429: 161- 176, 2001.
8. Couture R and Lindsey CJ. Brain kallikrein-kinin system: from receptors to neural pathways and physiological functions. In: Handbook of Chemical Neuroanatomy. Peptide Receptors, edited by Quirion R, Björklund A, and Hökfelt, T. Amsterdam, The Netherlands: Elsevier Science, 2000, part 1, vol. 16, p. 241-300.
9. Cushman DW, Wang FL, Fung WC, Grover GJ, Harvey CM, Scalese RJ, Mitch SL, and DeForrest JM. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE). Br J Clin Pharmacol 28: 115S-131S, 1989.
10. De Champlain J. Participation du système nerveux autonome dans l'hypertension. artérielle. Médecine Sciences 14, Suppl 2: 10-22, 1998.
11. De Champlain J. Pre- and postsynaptic adrenergic dysfunctions in hypertension. J Hypertens 8, Suppl 7: S77-S85, 1990.
12. De Sousa Buck H, Ongali B, Thibault G, Lindsey CJ, and Couture R. Autoradiographic detection of kinin receptors in the human medulla of control, hypertensive, and diabetic donors. Can J Physiol Pharmacol 80: 249-257, 2002.
13. 1 bradykinin receptor in normotension and hypertension. Circ Res 88: 275-281, 2001.
14. Erdös EG and Marcic BM. Kinins, receptors, kininases and inhibitors-where did they lead us? Biol Chem 382: 43-47, 2001.
15. 2 kinin receptors on receptor sequestration, ligand internalization, and signal transduction. J Biol Chem 273: 2617-2623, 1998.
16. 1 blockade with losartan. Hypertension 32: 280-286, 1998.
17. Hernandez-Hernandez R, Sosa-Canache B, Velasco M, Armas-Hernandez MJ, Armas-Padilla MC, and Cammarata R. Angiotensin II receptor antagonists role in arterial hypertension. J Hum Hypertens 16: S93-S99, 2002.
18. Hock FJ, Wirth K, Albus U, Linz W, Gerhards HJ, Wiemer G, Henke St Breipohl G, König W, Knolle J, and Schölkens BA. HOE 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharmacol 102: 769-773, 1991.
19. Hunter WM and Greenwood FC. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194:495-496, 1962.
20. Laneuville O, Reader TA, and Couture R. Intrathecal bradykinin acts presynaptically on spinal noradrenergic terminals to produce antinociception in the rat. Eur J Pharmacol 159: 273-283, 1989.
21. Linz W, Wiemer G, Gohlke P, Unger Th, and Scholkens BA. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 47: 25-49, 1995.
22. Linz W, Wohlfart P, Schölkens BA, Malinski T, and Wiemer G. Interactions among ACE, kinins and NO. Cardiovasc Res 43: 549-561, 1999.
23. Lopes P and Couture R. Cardiovascular responses elicited by intrathecal kinins in the conscious rat. Eur J Pharmacol 210: 137-147, 1992.
24. 8]bradykinin receptor binding sites in the rat spinal cord: effects of neonatal capsaicin, noradrenergic deafferentation, dorsal rhizotomy and peripheral axotomy. Neuroscience 68: 867-881, 1995.
25. 8]-bradykinin receptor binding sites in the guinea pig spinal cord. Synapse 15: 48-57, 1993.
26. 1 receptor in the spinal cord in humans and rats. Neuroreport 12: 2311-2314, 2001.
27. 1 receptors for kinins. Pharmacol Rev 50: 357-386, 1998.
28. 2 receptor expression in the rabbit. Am J Physiol Regul Integr Comp Physiol 277: R1568-R1578, 1999.
29. 1-receptors in normotensive rats and mice under chronic angiotensin-converting enzyme inhibitor treatment. Circulation 105: 627-632, 2002.
30. 2 receptors and angiotensin-converting enzyme in CHO cells. Circ Res 81: 848-856, 1997.
31. 2 receptors in sheep brain and spinal cord visualized by in vitro autoradiography. J Comp Neurol 381: 203-218, 1997.
32. 1) receptors in vivo. Eur J Pharmacol 160: 125-132, 1989.
33. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates (4th ed). San Diego, CA: Academic, 1998.
34. Petersen M, Eckert AS, Segond von Banchet G, Heppelmann B, Klusch A, and Kniffki KD Plasticity in the expression of bradykinin binding sites in sensory neurons after mechanical nerve injury. Neuroscience 83: 949-959, 1998.
35. 1 in human lung fibroblasts. Mol Pharmacol 56: 325-333, 1999.
36. 2 receptor mRNA expression in the hypothalamus of spontaneously hypertensive rats. Can J Physiol Pharmaco. 80: 258-263, 2002.
37. Ranadive SA, Chen AX, and Serajuddin AT. Relative lipophilicities and structural-pharmacological considerations of various angiotensin-converting enzyme (ACE) inhibitors. Pharmacol Res 9: 1480-1486, 1992.
38. Regoli D and Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 32: 1-46, 1980.
39. Regoli D, Rizzi A, Perron SI, and Gobeil F. Classification of kinin receptors. Biol Chem 382: 31-35, 2001.
40. 1-receptor in cultured human lung fibroblasts. J Clin Invest 101: 2080-2091, 1998.
41. Sica DA. Class effects of angiotensin-converting enzyme inhibitors. Am J Manag Care 6: S85-S108, 2000.
42. Varo N, Etayo JC, Zalba G, Beaumont J, Iraburu MJ, Montiel C, Gil MJ, Monreal I, and Diez J. Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats. J Hypertens 17: 107-114, 1999.
43. 1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain. Clin Exp Hypertens 20 205-221, 1998.
44. 1 receptor antagonist. Eur J Pharmacol 205: 217-218, 1991.
45. 1 receptor is constitutively expressed in the rat sensory nervous system. Neurosci Lett 294: 175-178, 2000.
46. 1 receptor gene expression through absence of internalization and resensitization. J Cell Biochem 78: 351-362, 2000.